Inactive Instrument

Calendar Chanticleer Holdings Inc Nasdaq

Equities

US15930P4046

End-of-day quote Nasdaq
- USD - Intraday chart for Chanticleer Holdings Inc

Chart calendar Chanticleer Holdings Inc

32346751cda9089f377df.9E2D2fHqawMAF4CsJsckrCmD4Jids4GvKrS5VW-dz_k.zCXsj5DHL2l3WuTNHo9Tw0Lqh_zNwLPMH976ZQCso8mMJ7CVta4jQXp24w~5cc1e5cfdebf8ba50e37ef13a8e2f914

Upcoming events on Chanticleer Holdings Inc

2024-05-07 Q2 2024 Earnings Release (Projected)
2024-08-11 Q3 2024 Earnings Release (Projected)
2024-12-11 Q4 2024 Earnings Release (Projected)
2025-02-17 Q1 2025 Earnings Release (Projected)

Past events on Chanticleer Holdings Inc

2024-04-10 09:00 am American Association for Cancer Research Meeting - Abstract Number: 7181
2024-02-14 07:30 am Q1 2024 Earnings Release
2023-12-14 04:15 pm Q4 2023 Earnings Release
2023-11-02 01:30 pm Connective Tissue Oncology Society Meeting - Abstract Number: 1566754
2023-08-31 Reverse Split: 1 of 22
2023-08-31 09:00 am Annual General Meeting
2023-08-14 08:00 am Q3 2023 Earnings Release
2023-08-07 12:00 pm BTIG Virtual Biotechnology Conference
2023-06-29 02:40 pm Cytokine-Based Drug Development Summit - Richard Kenney
2023-06-27 01:00 pm Cytokine-Based Drug Development Summit - John Cini
2023-05-10 07:30 am Q2 2023 Earnings Release
2023-04-18 05:00 pm American Association for Cancer Research Meeting
2023-04-18 01:30 pm American Association for Cancer Research Meeting - Abstract No: CT245
2023-02-13 08:00 am Q1 2023 Earnings Release
2022-11-02 08:30 am Business Update Call
2022-09-18 Reverse Split: 1 of 14
2022-08-15 04:05 pm Q3 2022 Earnings Release
2022-06-23 09:00 am Annual General Meeting
2022-05-10 08:15 am Interim 2022 Earnings Release
2022-04-13 09:00 am American Association of Cancer Research Meeting - Abstract Number: 4229

Annual results

Fiscal PeriodSeptember 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,48
0,00
-
0,35
0,40
-12.52%
0,15
0,15
1.47%

0,12

EBITDA
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

-12,4

EBIT
Million USD
Released
Forecast
Spread
0,00
0,00
-
-25,1
-24,7
-1.75%
0,00
0,00
-
-18,8
-16,7
-12.42%

-8,66

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00
0,00
-
-25,0
-24,5
-2.05%
0,00
0,00
-
-18,8
-16,7
-12.66%

-7,13

Net income
Million USD
Released
Forecast
Spread
0,00
0,00
-
-25,0
-24,5
-2.05%
0,00
0,00
-
-18,8
-16,7
-12.78%

-7,13

EPS
USD
Released
Forecast
Spread
0,00
0,00
-
-314
-320
1.92%
-150
-147
-2.4%
-18,1
-28,1
35.51%

-1,76

Announcement Date17/12/2017/12/2115/12/2214/12/23-

Quarterly results

Fiscal PeriodSeptember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD
Released
Forecast
Spread
0,13
0,00
-
0,10
0,05
90.64%
0,06
0,05
24.14%
0,06
0,10
-37.25%
0,04
0,10
-62.74%
0,04
0,00
-
0,04
0,00
-
0,04
0,02
99.57%
0,02
0,01
55.25%

0,01


0,02


0,02

EBIT
Million USD
Released
Forecast
Spread
-6,21
-8,68
28.4%
-8,21
-10,0
17.9%
-7,87
-9,00
12.59%












-3,60
-4,38
17.79%
-1,28
-3,64
64.84%

-1,60


-1,78


-1,97

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-6,20
-8,68
28.56%
-8,21
-10,0
17.92%
-7,88
-9,00
12.48%












-3,68
-4,38
16.04%
-1,17
-3,64
67.87%

0,55


-1,77


-1,96

Net income
Million USD
Released
Forecast
Spread
-6,20
-8,68
28.56%
-8,21
-10,0
17.92%
-7,88
-9,00
12.48%












-3,68
-4,38
16.04%
-1,17
-3,64
67.87%

0,55


-1,77


-1,96

EPS
USD
Released
Forecast
Spread
-30,8
-70,8
56.52%
-43,1
-40,0
-7.69%
-40,0
-43,1
7.14%
-37,2
-33,2
-11.92%
-17,6
-24,2
27.27%
-7,48
-10,9
31.31%
-2,86
-6,38
55.17%
-17,3
-4,09
-322.15%
-0,31
-0,86
63.95%

-0,28


-0,69


-0,48

Announcement Date08/02/2210/05/2215/08/2215/12/2213/02/2310/05/2314/08/2314/12/2314/02/24---
  1. Stock Market
  2. Equities
  3. SONN Stock
  4. Stock
  5. Calendar Chanticleer Holdings Inc